{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T12:51:28Z","timestamp":1782478288222,"version":"3.54.5"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,11,15]],"date-time":"2018-11-15T00:00:00Z","timestamp":1542240000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1007\/s00277-018-3551-y","type":"journal-article","created":{"date-parts":[[2018,11,15]],"date-time":"2018-11-15T15:35:32Z","timestamp":1542296132000},"page":"669-678","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Geriatric screening tools predict survival outcomes in older patients with diffuse large B cell lymphoma"],"prefix":"10.1007","volume":"98","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6687-4136","authenticated-orcid":false,"given":"Masatoshi","family":"Sakurai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daiki","family":"Karigane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidenori","family":"Kasahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiko","family":"Tanigawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akaru","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masao","family":"Kikuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumiko","family":"Kohashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,15]]},"reference":[{"key":"3551_CR1","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1046\/j.1440-1827.2000.01108.x","volume":"50","author":"Lymphoma Study Group of Japanese Pathologists","year":"2000","unstructured":"Lymphoma Study Group of Japanese Pathologists (2000) The World Health Organization classification of malignant lymphomas in Japan: incidence of recently recognized entities. Pathol Int 50:696\u2013702","journal-title":"Pathol Int"},{"key":"3551_CR2","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1038\/bjc.2011.450","volume":"105","author":"A Smith","year":"2011","unstructured":"Smith A, Howell D, Patmore R, Jack A, Roman E (2011) Incidence of haematological malignancy by sub-type: a report from the Haematological malignancy research network. Br J Cancer 105:1684\u20131692","journal-title":"Br J Cancer"},{"key":"3551_CR3","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1056\/NEJMoa011795","volume":"346","author":"B Coiffier","year":"2002","unstructured":"Coiffier B, Lepage E, Briere J et al (2002) CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 346:235\u2013242","journal-title":"N Engl J Med"},{"key":"3551_CR4","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/S1470-2045(11)70069-9","volume":"12","author":"F Peyrade","year":"2011","unstructured":"Peyrade F, Jardin F, Thieblemont C, Thyss A, Emile JF, Castaigne S, Coiffier B, Haioun C, Bologna S, Fitoussi O, Lepeu G, Fruchart C, Bordessoule D, Blanc M, Delarue R, Janvier M, Salles B, Andr\u00e9 M, Fournier M, Gaulard P, Tilly H (2011) Attenuated immunochemotherapy regimen (R-miniCHOP) in elderly patients older than 80 years with diffuse large B-cell lymphoma: a multicentre, single-arm, phase 2 trial. Lancet Oncol 12:460\u2013468","journal-title":"Lancet Oncol"},{"key":"3551_CR5","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.1200\/JCO.2013.54.8347","volume":"32","author":"H Wildiers","year":"2014","unstructured":"Wildiers H, Heeren P, Puts M, Topinkova E, Janssen-Heijnen MLG, Extermann M, Falandry C, Artz A, Brain E, Colloca G, Flamaing J, Karnakis T, Kenis C, Audisio RA, Mohile S, Repetto L, van Leeuwen B, Milisen K, Hurria A (2014) International Society of Geriatric Oncology consensus on geriatric assessment in older patients with cancer. J Clin Oncol 32:2595\u20132603","journal-title":"J Clin Oncol"},{"key":"3551_CR6","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.critrevonc.2007.11.001","volume":"65","author":"RA Audisio","year":"2008","unstructured":"Audisio RA, Pope D, Ramesh HS et al (2008) Shall we operate? Preoperative assessment in elderly cancer patients (PACE) can help. A SIOG surgical task force prospective study. Crit Rev Oncol Hematol 65:156\u2013163","journal-title":"Crit Rev Oncol Hematol"},{"key":"3551_CR7","doi-asserted-by":"publisher","first-page":"3457","DOI":"10.1200\/JCO.2011.34.7625","volume":"29","author":"A Hurria","year":"2011","unstructured":"Hurria A, Togawa K, Mohile SG, Owusu C, Klepin HD, Gross CP, Lichtman SM, Gajra A, Bhatia S, Katheria V, Klapper S, Hansen K, Ramani R, Lachs M, Wong FL, Tew WP (2011) Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study. J Clin Oncol 29:3457\u20133465","journal-title":"J Clin Oncol"},{"key":"3551_CR8","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3109\/10428194.2013.788176","volume":"55","author":"F Merli","year":"2014","unstructured":"Merli F, Luminari S, Rossi G, Mammi C, Marcheselli L, Ferrari A, Spina M, Tucci A, Stelitano C, Capodanno I, Fragasso A, Baldini L, Bottelli C, Montechiarello E, Fogazzi S, Lamorgese C, Cavalli L, Federico M, for the Fondazione Italiana Linfomi (2014) Outcome of frail elderly patients with diffuse large B-cell lymphoma prospectively identified by comprehensive geriatric assessment: results from a study of the Fondazione Italiana Linfomi. Leuk Lymphoma 55:38\u201343","journal-title":"Leuk Lymphoma"},{"key":"3551_CR9","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1634\/theoncologist.2011-0417","volume":"17","author":"M Spina","year":"2012","unstructured":"Spina M, Balzarotti M, Uziel L, Ferreri AJM, Fratino L, Magagnoli M, Talamini R, Giacalone A, Ravaioli E, Chimienti E, Berretta M, Lleshi A, Santoro A, Tirelli U (2012) Modulated chemotherapy according to modified comprehensive geriatric assessment in 100 consecutive elderly patients with diffuse large B-cell lymphoma. Oncologist 17:838\u2013846","journal-title":"Oncologist"},{"key":"3551_CR10","doi-asserted-by":"publisher","first-page":"4547","DOI":"10.1002\/cncr.24490","volume":"115","author":"A Tucci","year":"2009","unstructured":"Tucci A, Ferrari S, Bottelli C, Borlenghi E, Drera M, Rossi G (2009) A comprehensive geriatric assessment is more effective than clinical judgment to identify elderly diffuse large cell lymphoma patients who benefit from aggressive therapy. Cancer 115:4547\u20134553","journal-title":"Cancer"},{"key":"3551_CR11","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1093\/ageing\/afp097","volume":"38","author":"T Braes","year":"2009","unstructured":"Braes T, Flamaing J, Sterckx W, Lipkens P, Sabbe M, de Rooij SE, Schuurmans MJ, Moons P, Milisen K (2009) Predicting the risk of functional decline in older patients admitted to the hospital: a comparison of three screening instruments. Age Ageing 38:600\u2013603","journal-title":"Age Ageing"},{"key":"3551_CR12","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1197\/aemj.10.3.224","volume":"10","author":"SW Meldon","year":"2003","unstructured":"Meldon SW, Mion LC, Palmer RM et al (2003) A brief risk-stratification tool to predict repeat emergency department visits and hospitalizations in older patients discharged from the emergency department. Acad Emerg Med 10:224\u2013232","journal-title":"Acad Emerg Med"},{"key":"3551_CR13","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.1093\/annonc\/mdr587","volume":"23","author":"CA Bellera","year":"2012","unstructured":"Bellera CA, Rainfray M, Mathoulin-Pelissier S, Mertens C, Delva F, Fonck M, Soubeyran PL (2012) Screening older cancer patients: first evaluation of the G-8 geriatric screening tool. Ann Oncol 23:2166\u20132172","journal-title":"Ann Oncol"},{"key":"3551_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0115060","volume":"9","author":"P Soubeyran","year":"2014","unstructured":"Soubeyran P, Bellera C, Goyard J, Heitz D, Cur\u00e9 H, Rousselot H, Albrand G, Servent V, Jean OS, van Praagh I, Kurtz JE, P\u00e9rin S, Verhaeghe JL, Terret C, Desauw C, Girre V, Mertens C, Mathoulin-P\u00e9lissier S, Rainfray M (2014) Screening for vulnerability in older cancer patients: the ONCODAGE prospective multicenter cohort study. PLoS One 9:e115060","journal-title":"PLoS One"},{"key":"3551_CR15","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1002\/cncr.22495","volume":"109","author":"SG Mohile","year":"2007","unstructured":"Mohile SG, Bylow K, Dale W, Dignam J, Martin K, Petrylak DP, Stadler WM, Rodin M (2007) A pilot study of the vulnerable elders survey-13 compared with the comprehensive geriatric assessment for identifying disability in older patients with prostate cancer who receive androgen ablation. Cancer 109:802\u2013810","journal-title":"Cancer"},{"key":"3551_CR16","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1046\/j.1532-5415.2001.49281.x","volume":"49","author":"D Saliba","year":"2001","unstructured":"Saliba D, Elliott M, Rubenstein LZ, Solomon DH, Young RT, Kamberg CJ, Carol Roth RN, MacLean CH, Shekelle PG, Sloss EM, Wenger NS (2001) The vulnerable elders survey: a tool for identifying vulnerable older people in the community. J Am Geriatr Soc 49:1691\u20131699","journal-title":"J Am Geriatr Soc"},{"key":"3551_CR17","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1200\/JCO.2013.51.1345","volume":"32","author":"C Kenis","year":"2014","unstructured":"Kenis C, Decoster L, Van Puyvelde K et al (2014) Performance of two geriatric screening tools in older patients with cancer. J Clin Oncol 32:19\u201326","journal-title":"J Clin Oncol"},{"key":"3551_CR18","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1007\/s00277-013-2001-0","volume":"93","author":"ME Hamaker","year":"2014","unstructured":"Hamaker ME, Mitrovic M, Stauder R (2014) The G8 screening tool detects relevant geriatric impairments and predicts survival in elderly patients with a haematological malignancy. Ann Hematol 93:1031\u20131040","journal-title":"Ann Hematol"},{"key":"3551_CR19","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1002\/hon.2524","volume":"36","author":"T Hara","year":"2018","unstructured":"Hara T, Yoshikawa T, Goto H, Sawada M, Yamada T, Fukuno K, Kasahara S, Shibata Y, Matsumoto T, Mabuchi R, Nakamura N, Nakamura H, Ninomiya S, Kitagawa J, Kanemura N, Nannya Y, Katsumura N, Takahashi T, Kito Y, Takami T, Miyazaki T, Takeuchi T, Shimizu M, Tsurumi H (2018) R-THP-COP versus R-CHOP in patients younger than 70 years with untreated diffuse large B cell lymphoma: a randomized, open-label, noninferiority phase 3 trial. Hematol Oncol 36:638\u2013644. \n                    https:\/\/doi.org\/10.1002\/hon.2524","journal-title":"Hematol Oncol"},{"key":"3551_CR20","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1002\/hon.815","volume":"25","author":"H Tsurumi","year":"2007","unstructured":"Tsurumi H, Hara T, Goto N, Kanemura N, Kasahara S, Sawada M, Yasuda I, Yamada T, Shimizu M, Takami T, Moriwaki H (2007) A phase II study of a THP-COP regimen for the treatment of elderly patients aged 70 years or older with diffuse large B-cell lymphoma. Hematol Oncol 25:107\u2013114","journal-title":"Hematol Oncol"},{"key":"3551_CR21","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1007\/s00277-016-2768-x","volume":"95","author":"K Laribi","year":"2016","unstructured":"Laribi K, Denizon N, Bolle D, Truong C, Besan\u00e7on A, Sandrini J, Anghel A, Farhi J, Ghnaya H, Baugier de Materre A (2016) R-CVP regimen is active in frail elderly patients aged 80 or over with diffuse large B cell lymphoma. Ann Hematol 95:1705\u20131714","journal-title":"Ann Hematol"},{"key":"3551_CR22","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1007\/s00277-010-0956-7","volume":"89","author":"T Hirakawa","year":"2010","unstructured":"Hirakawa T, Yamaguchi H, Yokose N, Gomi S, Inokuchi K, Dan K (2010) Importance of maintaining the relative dose intensity of CHOP-like regimens combined with rituximab in patients with diffuse large B-cell lymphoma. Ann Hematol 89:897\u2013904","journal-title":"Ann Hematol"},{"key":"3551_CR23","volume-title":"Manual of nursing diagnosis","author":"M Gordon","year":"2014","unstructured":"Gordon M (2014) Manual of nursing diagnosis. Jones & Bartlett Learning, Massachusetts"},{"key":"3551_CR24","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373\u2013383","journal-title":"J Chronic Dis"},{"key":"3551_CR25","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda Y (2013) Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics. Bone Marrow Transplant 48:452\u2013458","journal-title":"Bone Marrow Transplant"},{"key":"3551_CR26","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1182\/blood-2005-06-2508","volume":"107","author":"LM Morton","year":"2006","unstructured":"Morton LM, Wang SS, Devesa SS, Hartge P, Weisenburger DD, Linet MS (2006) Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood 107:265\u2013276","journal-title":"Blood"},{"key":"3551_CR27","doi-asserted-by":"publisher","first-page":"3145","DOI":"10.1002\/cncr.30173","volume":"122","author":"D Chihara","year":"2016","unstructured":"Chihara D, Westin JR, Oki Y, Ahmed MA, Do B, Fayad LE, Hagemeister FB, Romaguera JE, Fanale MA, Lee HJ, Turturro F, Samaniego F, Neelapu SS, Rodriguez MA, Fowler NH, Wang M, Davis RE, Nastoupil LJ (2016) Management strategies and outcomes for very elderly patients with diffuse large B-cell lymphoma. Cancer 122:3145\u20133151","journal-title":"Cancer"},{"key":"3551_CR28","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1093\/annonc\/mdl034","volume":"17","author":"O Bairey","year":"2006","unstructured":"Bairey O, Benjamini O, Blickstein D, Elis A, Ruchlemer R (2006) Non-Hodgkin's lymphoma in patients 80 years of age or older. Ann Oncol 17:928\u2013934","journal-title":"Ann Oncol"},{"key":"3551_CR29","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1093\/annonc\/mdm563","volume":"19","author":"C Thieblemont","year":"2008","unstructured":"Thieblemont C, Grossoeuvre A, Houot R et al (2008) Non-Hodgkin\u2019s lymphoma in very elderly patients over 80 years. A descriptive analysis of clinical presentation and outcome. Ann Oncol 19:774\u2013779","journal-title":"Ann Oncol"},{"key":"3551_CR30","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1111\/bjh.13619","volume":"173","author":"TA Eyre","year":"2016","unstructured":"Eyre TA, Salisbury R, Eyre DW, Watson C, Collins GP, Hatton CS (2016) Results of a large retrospective analysis of the effect of intended dose intensity of R-CHOP on outcome in a cohort of consecutive, unselected elderly patients with de novo diffuse large B cell lymphoma. Br J Haematol 173:487\u2013491","journal-title":"Br J Haematol"},{"key":"3551_CR31","doi-asserted-by":"publisher","first-page":"581","DOI":"10.3109\/10428194.2011.621565","volume":"53","author":"F Merli","year":"2012","unstructured":"Merli F, Luminari S, Rossi G et al (2012) Cyclophosphamide, doxorubicin, vincristine, prednisone and rituximab versus epirubicin, cyclophosphamide, vinblastine, prednisone and rituximab for the initial treatment of elderly \u201cfit\u201d patients with diffuse large B-cell lymphoma: results from the ANZINTER3 trial of the Intergruppo Italiano Linfomi. Leuk Lymphoma 53:581\u2013588","journal-title":"Leuk Lymphoma"},{"key":"3551_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/10428194.2018.1480773","volume":"4","author":"S Beygi","year":"2018","unstructured":"Beygi S, Sadashiv S, Reilly JB, Khan C, Lister J (2018) Frontline treatment of diffuse large B-cell lymphoma in elderly: a systematic review of clinical trials in post-rituximab era. Leuk Lymphoma 4:1\u201315","journal-title":"Leuk Lymphoma"},{"key":"3551_CR33","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1111\/j.1349-7006.2008.00813.x","volume":"99","author":"Y Shimoyama","year":"2008","unstructured":"Shimoyama Y, Yamamoto K, Asano N, Oyama T, Kinoshita T, Nakamura S (2008) Age-related Epstein-Barr virus-associated B-cell lymphoproliferative disorders: special references to lymphomas surrounding this newly recognized clinicopathologic disease. Cancer Sci 99:1085\u20131091","journal-title":"Cancer Sci"},{"key":"3551_CR34","doi-asserted-by":"publisher","first-page":"e344","DOI":"10.1016\/S1470-2045(12)70234-6","volume":"13","author":"F Peyrade","year":"2012","unstructured":"Peyrade F, Gastaud L, Re D, Pacquelet-Cheli S, Thyss A (2012) Treatment decisions for elderly patients with haematological malignancies: a dilemma. Lancet Oncol 13:e344\u2013e352","journal-title":"Lancet Oncol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-018-3551-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-018-3551-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-018-3551-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,14]],"date-time":"2019-11-14T19:09:01Z","timestamp":1573758541000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-018-3551-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,15]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["3551"],"URL":"https:\/\/doi.org\/10.1007\/s00277-018-3551-y","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,15]]},"assertion":[{"value":"17 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. For this type of study, formal consent is not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The study was approved by the ethics boards of the institution.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}